ロード中...
Radioiodine remnant ablation in low-risk differentiated thyroid cancer patients who had R0 dissection is an over treatment
Low-risk (LR) differentiated thyroid cancer (DTC) patients should be ablated or not, albeit, with small dose of radioiodine is highly controversial. We hypothesized that those LR DTC patients who were surgically ablated need no radioiodine remnant ablation (RRA). This study aims to evaluate the long...
保存先:
| 出版年: | Cancer Med |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley & Sons, Ltd
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4529341/ https://ncbi.nlm.nih.gov/pubmed/25755077 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.443 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|